Our prior study identified G0S2 as a direct retinoid target gene that was markedly induced after in vitro RA-treatment of cultured NB4 APL cells and leukemic cells from APL patients as well as after in vivo RA-treatment of transgenic APL mice (9). This evidence concerns the gene G0S2 and rheumatoid arthritis.